Labcorp Holdings annual stock-based compensation
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Stock-Based Compensation Growth & History (LH)
Labcorp Holdings's stock-based compensation was $125.8M for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $125.8M | $9.1M | +7.80% |
| 2024 | 2024-12-31 | $116.7M | −$12.0M | −9.32% |
| 2023 | 2023-12-31 | $128.7M | $11.9M | +10.19% |
| 2022 | 2022-12-31 | $116.8M | −$16.1M | −12.11% |
| 2021 | 2021-12-31 | $132.9M | $21.2M | +18.98% |
| 2020 | 2020-12-31 | $111.7M | $4.7M | +4.39% |
| 2019 | 2019-12-31 | $107.0M | $15.4M | +16.81% |
| 2018 | 2018-12-31 | $91.6M | −$18.1M | −16.50% |
| 2017 | 2017-12-31 | $109.7M | $100,000 | +0.09% |
| 2016 | 2016-12-31 | $109.6M | $7.5M | +7.35% |
| 2015 | 2015-12-31 | $102.1M | $56.4M | +123.41% |
| 2014 | 2014-12-31 | $45.7M | $8.4M | +22.52% |
| 2013 | 2013-12-31 | $37.3M | −$3.4M | −8.35% |
| 2012 | 2012-12-31 | $40.7M | −$8.2M | −16.77% |
| 2011 | 2011-12-31 | $48.9M | $8.9M | +22.25% |
| 2010 | 2010-12-31 | $40.0M | $3.6M | +9.89% |
| 2009 | 2009-12-31 | $36.4M | $200,000 | +0.55% |
| 2008 | 2008-12-31 | $36.2M | $800,000 | +2.26% |
| 2007 | 2007-12-31 | $35.4M | — | — |
Labcorp Holdings quarterly stock-based compensation
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $34.9M | $800,000 | +2.35% |
| Q1 2026 | 2026-03-31 | $31.7M | −$1.1M | −3.35% |
| Q4 2025 | 2025-12-31 | $29.7M | $2.4M | +8.79% |
| Q3 2025 | 2025-09-30 | $29.2M | $2.2M | +8.15% |
| Q2 2025 | 2025-06-30 | $34.1M | $3.3M | +10.71% |
| Q1 2025 | 2025-03-31 | $32.8M | $1.2M | +3.80% |
| Q4 2024 | 2024-12-31 | $27.3M | $300,000 | +1.11% |
| Q3 2024 | 2024-09-30 | $27.0M | −$7.4M | −21.51% |
| Q2 2024 | 2024-06-30 | $30.8M | −$3.6M | −10.47% |
| Q1 2024 | 2024-03-31 | $31.6M | −$1.3M | −3.95% |
| Q4 2023 | 2023-12-31 | $27.0M | $3.4M | +14.41% |
| Q3 2023 | 2023-09-30 | $34.4M | $4.9M | +16.61% |
| Q2 2023 | 2023-06-30 | $34.4M | $8.9M | +34.90% |
| Q1 2023 | 2023-03-31 | $32.9M | −$5.3M | −13.87% |
| Q4 2022 | 2022-12-31 | $23.6M | $2.3M | +10.80% |
| Q3 2022 | 2022-09-30 | $29.5M | −$29.5M | −50.00% |
| Q2 2022 | 2022-06-30 | $25.5M | $1.6M | +6.69% |
| Q1 2022 | 2022-03-31 | $38.2M | $9.5M | +33.10% |
| Q4 2021 | 2021-12-31 | $21.3M | −$5.5M | −20.52% |
| Q3 2021 | 2021-09-30 | $59.0M | $31.8M | +116.91% |
| Q2 2021 | 2021-06-30 | $23.9M | −$15.9M | −39.95% |
| Q1 2021 | 2021-03-31 | $28.7M | $10.8M | +60.34% |
| Q4 2020 | 2020-12-31 | $26.8M | $3.3M | +14.04% |
| Q3 2020 | 2020-09-30 | $27.2M | −$4.3M | −13.65% |
| Q2 2020 | 2020-06-30 | $39.8M | $13.3M | +50.19% |
| Q1 2020 | 2020-03-31 | $17.9M | −$7.6M | −29.80% |
| Q4 2019 | 2019-12-31 | $23.5M | $2.7M | +12.98% |
| Q3 2019 | 2019-09-30 | $31.5M | $12.7M | +67.55% |
| Q2 2019 | 2019-06-30 | $26.5M | $300,000 | +1.15% |
| Q1 2019 | 2019-03-31 | $25.5M | −$300,000 | −1.16% |
| Q4 2018 | 2018-12-31 | $20.8M | −$3.1M | −12.97% |
| Q3 2018 | 2018-09-30 | $18.8M | −$14.3M | −43.20% |
| Q2 2018 | 2018-06-30 | $26.2M | $1.2M | +4.80% |
| Q1 2018 | 2018-03-31 | $25.8M | −$1.9M | −6.86% |
| Q4 2017 | 2017-12-31 | $23.9M | −$3.8M | −13.72% |
| Q3 2017 | 2017-09-30 | $33.1M | $8.8M | +36.21% |
| Q2 2017 | 2017-06-30 | $25.0M | −$800,000 | −3.10% |
| Q1 2017 | 2017-03-31 | $27.7M | −$4.1M | −12.89% |
| Q4 2016 | 2016-12-31 | $27.7M | $3.3M | +13.52% |
| Q3 2016 | 2016-09-30 | $24.3M | $600,000 | +2.53% |
| Q2 2016 | 2016-06-30 | $25.8M | −$1.9M | −6.86% |
| Q1 2016 | 2016-03-31 | $31.8M | $5.5M | +20.91% |
| Q4 2015 | 2015-12-31 | $24.4M | — | — |
| Q3 2015 | 2015-09-30 | $23.7M | $12.2M | +106.09% |
| Q2 2015 | 2015-06-30 | $27.7M | — | — |
| Q1 2015 | 2015-03-31 | $26.3M | −$19.4M | −42.45% |
| Q3 2014 | 2014-09-30 | $11.5M | $4.7M | +69.12% |
| Q1 2014 | 2014-03-31 | $45.7M | $34.4M | +304.42% |
| Q4 2013 | 2013-12-31 | $8.4M | $2.5M | +42.37% |
| Q3 2013 | 2013-09-30 | $6.8M | −$4.3M | −38.74% |
| Q2 2013 | 2013-06-30 | $10.8M | −$1.1M | −9.24% |
| Q1 2013 | 2013-03-31 | $11.3M | −$500,000 | −4.24% |
| Q4 2012 | 2012-12-31 | $5.9M | −$5.8M | −49.57% |
| Q3 2012 | 2012-09-30 | $11.1M | −$600,000 | −5.13% |
| Q2 2012 | 2012-06-30 | $11.9M | −$500,000 | −4.03% |
| Q1 2012 | 2012-03-31 | $11.8M | −$1.3M | −9.92% |
| Q4 2011 | 2011-12-31 | $11.7M | $1.2M | +11.43% |
| Q3 2011 | 2011-09-30 | $11.7M | $1.6M | +15.84% |
| Q2 2011 | 2011-06-30 | $12.4M | $1.7M | +15.89% |
| Q1 2011 | 2011-03-31 | $13.1M | $4.4M | +50.57% |
| Q4 2010 | 2010-12-31 | $10.5M | $200,000 | +1.94% |
| Q3 2010 | 2010-09-30 | $10.1M | $800,000 | +8.60% |
| Q2 2010 | 2010-06-30 | $10.7M | $1.1M | +11.46% |
| Q1 2010 | 2010-03-31 | $8.7M | $1.5M | +20.83% |
| Q4 2009 | 2009-12-31 | $10.3M | — | — |
| Q3 2009 | 2009-09-30 | $9.3M | $200,000 | +2.20% |
| Q2 2009 | 2009-06-30 | $9.6M | — | — |
| Q1 2009 | 2009-03-31 | $7.2M | — | — |
| Q3 2008 | 2008-09-30 | $9.1M | — | — |
Labcorp Holdings stock-based compensation trends
Over the last five fiscal years, Labcorp Holdings's stock-based compensation increased from $111.7M to $125.8M, a change of $14.1M. The latest reported quarter, Q2 2026, shows $34.9M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...